Search research articles
Contact Us
Filters
Showing results (331-340 of 401) with videos related to
Page
of 41
Sort By:
The Journal of Infectious Diseases
|
July 1, 1995
Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain
B Nonnenmacher, N L Hubbert, R Kirnbauer, et al.
Leukemia
|
June 25, 2026
Role of endothelial Dlc1 in embryonic vascular development and adult bone marrow hematopoiesis
Jing-Xin Feng, Marian E Durkin, Mei-Ting Yang, et al.
Mbio
|
August 7, 2014
Maturation of the human papillomavirus 16 capsid
Giovanni Cardone, Adam L Moyer, Naiqian Cheng, et al.
Cancer Journal (Sudbury, Mass.)
|
March 25, 2022
Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining Progress
Donna R Rivera, Paul G Kluetz, Kald Abdallah, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
SRSF3 is oncogenic in breast but tumor-suppressive in liver by differential regulation of gene expression
Lulu Yu, Masahiko Ajiro, Alexei Lobanov, et al.
The Journal of Infectious Diseases
|
December 1, 1995
Divergent human papillomavirus type 16 variants are serologically cross-reactive
G Cheng, J P Icenogle, R Kirnbauer, et al.
Virology
|
May 1, 1996
Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization
R Kirnbauer, L M Chandrachud, B W O'Neil, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 1998
Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
H L Greenstone, J D Nieland, K E de Visser, et al.
American Journal of Obstetrics and Gynecology
|
February 20, 2016
Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
Allan Hildesheim, Paula Gonzalez, Aimee R Kreimer, et al.
The Journal of Cell Biology
|
November 9, 2017
Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1
Brajendra K Tripathi, Tiera Grant, Xiaolan Qian, et al.
Page
of 41
Search research articles
Search
Showing results (331-340 of 401) with videos related to
Sort By:
Page
of 41
The Journal of Infectious Diseases
|
July 1, 1995
Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain
B Nonnenmacher, N L Hubbert, R Kirnbauer, et al.
Leukemia
|
June 25, 2026
Role of endothelial Dlc1 in embryonic vascular development and adult bone marrow hematopoiesis
Jing-Xin Feng, Marian E Durkin, Mei-Ting Yang, et al.
Mbio
|
August 7, 2014
Maturation of the human papillomavirus 16 capsid
Giovanni Cardone, Adam L Moyer, Naiqian Cheng, et al.
Cancer Journal (Sudbury, Mass.)
|
March 25, 2022
Clinical Evidence Generation During a Pandemic: Lessons Learned for Sustaining Progress
Donna R Rivera, Paul G Kluetz, Kald Abdallah, et al.
Biorxiv : the Preprint Server for Biology
|
June 26, 2025
SRSF3 is oncogenic in breast but tumor-suppressive in liver by differential regulation of gene expression
Lulu Yu, Masahiko Ajiro, Alexei Lobanov, et al.
The Journal of Infectious Diseases
|
December 1, 1995
Divergent human papillomavirus type 16 variants are serologically cross-reactive
G Cheng, J P Icenogle, R Kirnbauer, et al.
Virology
|
May 1, 1996
Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization
R Kirnbauer, L M Chandrachud, B W O'Neil, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 21, 1998
Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
H L Greenstone, J D Nieland, K E de Visser, et al.
American Journal of Obstetrics and Gynecology
|
February 20, 2016
Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
Allan Hildesheim, Paula Gonzalez, Aimee R Kreimer, et al.
The Journal of Cell Biology
|
November 9, 2017
Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1
Brajendra K Tripathi, Tiera Grant, Xiaolan Qian, et al.
Page
of 41